ALZAMEND NEURO INC (ALZN) Forecast, Price Target & Analyst Ratings

NASDAQ:ALZN • US02262M6057

Current stock price

1.83 USD
-0.06 (-3.17%)
At close:
1.7736 USD
-0.06 (-3.08%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ALZAMEND NEURO INC (ALZN).

Forecast Snapshot

Consensus Price Target

Price Target
$28.56
+ 1,460.66% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
N/A
Period
Q4 / 2026
EPS Estimate
-$0.74
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
80.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$28.56
Upside
+ 1,460.66%
From current price of $1.83 to mean target of $28.56, Based on 8 analyst forecasts
Low
$28.28
Median
$28.56
High
$29.40

Price Target Revisions

1 Month
0.00%
3 Months
-33.33%

Price Target Summary

8 Wall Street analysts provided a forecast for the next 12 months for ALZN. The average price target is 28.56 USD. This implies a price increase of 1460.66% is expected in the next year compared to the current price of 1.83.
The average price target has been revised downward by 33.33% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

ALZN Current Analyst RatingALZN Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

ALZN Historical Analyst RatingsALZN Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
80.00%
ALZN was analyzed by 8 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about ALZN.
In the previous month the buy percentage consensus was at a similar level.
ALZN was analyzed by 8 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-12-22Ascendiant CapitalMaintains Buy -> Buy
2025-09-25Ascendiant CapitalMaintains Buy -> Buy
2025-08-21Ascendiant CapitalMaintains Buy -> Buy
2025-03-17Ascendiant CapitalMaintains Buy -> Buy
2024-12-16Ascendiant CapitalMaintains Buy -> Buy
2024-11-11Ascendiant CapitalMaintains Buy -> Buy
2023-04-12Maxim GroupInitiate Buy
2021-10-01Ascendiant CapitalInitiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
N/A
Period
Q4 / 2026
EPS Estimate
-$0.74
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
78.52%
Number of Analysts
4

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
6.55%

Next Earnings Summary

→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
ALZN revenue by date.ALZN revenue by date.
N/AN/AN/AN/AN/A
322.64%		N/A
72.64%		N/A
47.44%		N/A
30.21%
EBITDA
YoY % growth
ALZN ebitda by date.ALZN ebitda by date.
N/AN/AN/A-12.32M-14.85M
-20.54%		-9.887M
33.42%		-4.446M
55.03%		N/A
-85.83%		N/A
-30.86%		N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
ALZN ebit by date.ALZN ebit by date.
-5.01M-4.42M
11.78%		-4.95M
-11.99%		-12.32M
-148.89%		-14.87M
-20.70%		-9.938M
33.17%		-4.497M
54.75%		N/A
-114.79%		N/A
-69.08%		N/A
-78.50%		N/A
69.67%		N/A
911.99%		N/A
118.63%		N/A
60.05%		N/A
35.12%
Operating Margin
ALZN operating margin by date.ALZN operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
ALZN eps by date.ALZN eps by date.
N/AN/AN/AN/A-202.50
-17.65%		-247.95
-22.44%		N/A
94.04%		N/A
67.29%		N/A
37.03%		N/A
-1.84%		N/A
71.71%		N/A
912.79%		N/A
106.72%		N/A
54.39%		N/A
31.65%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28 Q4 / 28
EPS
Q2Q % growth		-0.74
78.52%		-1.00
21.51%		-1.02
-240.00%		-0.70
-20.47%		-0.70
5.52%		-0.77
23.86%		-0.80
22.00%		-0.75
-8.03%		-0.79
-12.41%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		-2.55M
-134.33%		-2.652M
0.77%		-2.652M
-181.32%		-2.652M
-36.84%		-2.652M
-4.00%		N/AN/AN/AN/A
EBIT
Q2Q % growth		-2.83M
-148.48%		-3.866M
-43.19%		-3.974M
-298.20%		-4.191M
-79.04%		-4.299M
-51.92%		-6.704M
-73.41%		-6.996M
-76.03%		-7.58M
-80.85%		-7.871M
-83.08%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

ALZN Yearly Revenue VS EstimatesALZN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2029 2030 2031 2032 2033 100M 200M 300M 400M
ALZN Yearly EPS VS EstimatesALZN Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -50 -100 -150 -200

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
25.73%
EPS Next 5 Year
14.83%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

ALZAMEND NEURO INC / ALZN Forecast FAQ

What is the average price target for ALZAMEND NEURO INC (ALZN) stock?

8 analysts have analysed ALZN and the average price target is 28.56 USD. This implies a price increase of 1460.66% is expected in the next year compared to the current price of 1.83.

Can you provide the consensus estimates for ALZAMEND NEURO INC next earnings?

The consensus EPS estimate for the next earnings of ALZAMEND NEURO INC (ALZN) is -0.74 USD and the consensus revenue estimate is 0 USD.

How many analysts cover ALZAMEND NEURO INC (ALZN) stock?

The number of analysts covering ALZAMEND NEURO INC (ALZN) is 8.